Low-Grade Glioma
Author Technology and dose prescription N Results Follow-up Debus et al. (Debus et al. 1999) Median 52.4 Gy/1.6–2.0 Gy Margin: 7 mm 10 5-year PFS: 90% 12–72 mos 5-year OS: 100%…
Brainstem Tumors
Fig. 13.1 (a) A midbrain JPA in a 6-year-old boy who presented with a right VI nerve deficit and a right hemiparesis. (b) Macroscopic residual disease following initial surgery was…
Optic Pathway Glioma
Fig. 11.1 Left optic nerve glioma (a) enhancing on contrast-enhanced T1-weighted magnetic resonance sequence and (b) hyperintense on a contrast-enhanced T2-weighted magnetic resonance sequence Fig. 11.2 Bulky extension of a…
Atypical Teratoid Rhabdoid Tumors (AT/RT) and ETMR
Fig. 8.1 MRI of supratentorial AT/RT in a 19-month-old boy. (a) Axial T1 with contrast. (b) Axial T2 FLAIR sequence Some authors have suggested that the presence of wavy, band-like…
Proton Therapy for Pediatric Brain Tumors
Fig. 26.1 (a, b) Isodose comparison of proton and photon craniospinal irradiation (CSI) with elimination of exit dose through the patient’s neck, chest, abdomen and pelvis. (c) Isodose distribution of…
Pediatric Brain Metastases
Fig. 22.1 (a) Contrast-enhanced CT scan with solitary ring-enhancing lesion (white arrow), (b) contrast-enhanced T1-weigted MRI with solitary ring-enhancing lesion with hypointense necrotic core (white arrow), (c) T2-weighted MRI and…
Neuropsychological Late Effects of Radiotherapy for Pediatric Brain Tumors
Neurocognitive domain Intellectual/global cognitive functioning Academic achievement Visuospatial and motor Attention and working memory Memory Processing speed Executive functioning Measurement instrument WISC Full Scale IQ WJ-Achievement WISC Perceptual Reasoning…
Reirradiation
Author technique year Median PFS post RT2 Median OS post RT2 Median PFS No RT2 Median OS No RT2 Merchant FFRT 2008 NA 67% at 5 years NA NA Merchant CSI…
